Your browser doesn't support javascript.
loading
Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer.
Cejalvo, Juan Miguel; Pérez-Fidalgo, J Alejandro; Ribas, Gloria; Burgués, Octavio; Mongort, Cristina; Alonso, Elisa; Ibarrola-Villava, Maider; Bermejo, Begoña; Martínez, María Teresa; Cervantes, Andrés; Lluch, Ana.
Afiliação
  • Cejalvo JM; Department of Haematology and Medical Oncology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, AVD/Blasco Ibánez, 17, 46010, Valencia, Spain. juanmiguel.cejalvo@irbbarcelona.org.
  • Pérez-Fidalgo JA; Department of Haematology and Medical Oncology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, AVD/Blasco Ibánez, 17, 46010, Valencia, Spain.
  • Ribas G; Department of Haematology and Medical Oncology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, AVD/Blasco Ibánez, 17, 46010, Valencia, Spain.
  • Burgués O; Department of Haematology and Medical Oncology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, AVD/Blasco Ibánez, 17, 46010, Valencia, Spain.
  • Mongort C; Department of Pathology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Alonso E; Department of Pathology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
  • Ibarrola-Villava M; Department of Haematology and Medical Oncology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, AVD/Blasco Ibánez, 17, 46010, Valencia, Spain.
  • Bermejo B; Department of Haematology and Medical Oncology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, AVD/Blasco Ibánez, 17, 46010, Valencia, Spain.
  • Martínez MT; Department of Haematology and Medical Oncology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, AVD/Blasco Ibánez, 17, 46010, Valencia, Spain.
  • Cervantes A; Department of Haematology and Medical Oncology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, AVD/Blasco Ibánez, 17, 46010, Valencia, Spain.
  • Lluch A; Department of Haematology and Medical Oncology. Hospital Clínico Universitario, Biomedical Research Institute INCLIVA, University of Valencia, AVD/Blasco Ibánez, 17, 46010, Valencia, Spain. lluch_ana@gva.es.
Breast Cancer Res Treat ; 160(1): 69-77, 2016 11.
Article em En | MEDLINE | ID: mdl-27628192
Assuntos
Palavras-chave
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas ras / Fosfatidilinositol 3-Quinases / Proteínas Proto-Oncogênicas B-raf / Proteínas Proto-Oncogênicas c-akt / Mutação Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha País de publicação: Holanda
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteínas ras / Fosfatidilinositol 3-Quinases / Proteínas Proto-Oncogênicas B-raf / Proteínas Proto-Oncogênicas c-akt / Mutação Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha País de publicação: Holanda